Review article: novel oral-targeted therapies in inflammatory bowel disease

Author:

White J. R.1ORCID,Phillips F.1,Monaghan T.1,Fateen W.1,Samuel S.1,Ghosh S.2,Moran G. W.1

Affiliation:

1. NIHR Biomedical Research Centre in Gastrointestinal and Liver Diseases at Nottingham University Hospitals NHS Trust; The University of Nottingham; Nottingham UK

2. NIHR Biomedical Research Centre; Institute of Translational Medicine; College of Medical and Dental Sciences; University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Reference128 articles.

1. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies;Frolkis;Gastroenterology,2013

2. Cumulative incidence of second intestinal resection in Crohn's disease: a systematic review and meta-analysis of population-based studies;Frolkis;Am J Gastroenterol,2014

3. Surgical rates for Crohn's disease are decreasing: a population-based time trend analysis and validation study;Ma;Am J Gastroenterol,2017

4. The burden of inflammatory bowel disease in Europe;Burisch;J Crohns Colitis,2013

5. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis;Timmer;Cochrane Database Syst Rev,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3